Letter of Intent Deadline: April 15, 2025 @ 12:00 p.m. (noon) ET
Award Amount: $60,000 a year for up to 2 years
The PhRMA Foundation Postdoctoral Fellowship in Drug Delivery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.
Program Goals
Delivering today’s increasingly complex drugs to patients demands novel approaches in technology development, formulation, manufacturing, as well as prediction and demonstration of in vivo performance. The PhRMA Foundation seeks to fund research exploring:
- formulation composition, drug dosage, and delivery modalities/technologies that enable desired pharmacokinetics and pharmacodynamics (absorption, targeting, elimination, etc.) of drugs
- formulation and manufacturing methods that achieve enhanced product quality of challenging chemical entities (e.g., poorly soluble drugs, large molecules, cell-based constructs)
- predictive approaches (e.g., modeling, simulation, data analytics, and machine and deep learning) that seek to achieve in vitro and in vivo correlation (IVIVC); bridge a drug’s critical quality attributes and in vivo performance (PK, efficacy, and toxicity); and facilitate assessment of toxicities and side effects of a drug delivery system
Proposals that involve artificial intelligence (AI) approaches (i.e., data-driven ML/DL) should clearly document and reference the methodology, explain the data curation process (sources, quality, quantity), and discuss the wet lab validation process. Expected pitfalls and alternative strategies should be described as well.
Research on delivery technologies applicable to multiple drug modalities will be prioritized.
For eligibility information and to apply, please see the InfoReady application link.